Press-release for stocks

Professional, Scientific, and T...

| Email alert Add to watchlist
publication treatment research preclinical for leukemia

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
IPSC | $3.19 4.59% 32K

| Email alert Add to watchlist
genetic cell therapeutics therapy

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Published: 2024-04-23 (Crawled : 05:00) - prnewswire.com
VRTX | $405.135 1.3% 280K

| 0.0% | O: 1.87% H: 0.0% C: 0.0%
cell for collaboration therapeutics diabetes agreement

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
PRQR | News | $2.085 4.25% 110K

Professional, Scientific, and T...

| 0.0% | O: 2.5% H: 0.0% C: 0.0%
meeting

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
OMGA | $2.365 -1.05% 130K

| -4.02% | O: -0.8% H: 0.0% C: 0.0%
cell preclinical meeting therapeutics therapy

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
HOWL | $6.14 0.82% 120K

| 1.5% | O: 3.92% H: 0.0% C: 0.0%
il-10 first disease preclinical for meeting therapeutics potential therapy

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
AUTL | $4.555 -0.11% 800K

| 0.88% | O: 1.22% H: 0.0% C: 0.0%
first conference report therapeutics financial results

Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
LSTA | $2.67 7.9K

Manufacturing

| Email alert Add to watchlist
first pancreatic trial therapeutics china

Halozyme to Report First Quarter 2024 Financial and Operating Results
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
HALO M | $39.115 1.05% 120K

| 0.0% | O: 0.93% H: 0.0% C: 0.0%
first report financial results

Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
ACRS | $1.225 0.41% 310K

| 0.0% | O: 2.05% H: 0.0% C: 0.0%
therapeutics

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Sharecare, Inc. with Losses to Contact the Firm
Published: 2024-04-23 (Crawled : 14:30) - prnewswire.com
SHCR | $0.7208 3.39% 780K

| 0.0% | O: 5.19% H: 0.0% C: 0.0%
GL | News | $75.64 13.93% 5.5M

| 0.0% | O: 1.57% H: 0.0% C: 0.0%
CKPT | $1.48 2.07% 170K

| 0.0% | O: 4.14% H: 0.0% C: 0.0%
deadline

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Globe Life Inc. and Encourages Investors with Losses to Contact the Firm
Published: 2024-04-23 (Crawled : 14:30) - prnewswire.com
GL | News | $75.64 13.93% 5.5M

| 0.0% | O: 1.57% H: 0.0% C: 0.0%
CKPT | $1.48 2.07% 170K

| 0.0% | O: 4.14% H: 0.0% C: 0.0%
life

Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
JNJ | News | $150.09 0.65% 3.9M

| 0.53% | O: 0.89% H: 0.0% C: 0.0%
VXRT | News | $0.7744 1.56% 350K

| 0.0% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $47.85 1.49% 920K

| 0.0% | O: 1.7% H: 0.0% C: 0.0%
PTCT | News S | $25.72 -0.96% 140K

| 0.0% | O: 0.02% H: 0.0% C: 0.0%
NKTR | News | $1.4 2.94% 600K

| 0.0% | O: 1.84% H: 0.0% C: 0.0%
MOR | News | $18.01 0.28% 130K

| 0.0% | O: 0.39% H: 0.0% C: 0.0%
GLPG | News | $29.695 2.15% 69K

| 0.0% | O: 0.38% H: 0.0% C: 0.0%
AMRN | News | $0.8888 2.67% 360K

| 0.0% | O: 0.57% H: 0.0% C: 0.0%
GOOGL | News S | $158.54 1.45% 11M

| 0.0% | O: 0.48% H: 0.0% C: 0.0%
GOOG | News S | $160.1 1.36% 7.6M

Professional, Scientific, and T...

| 0.0% | O: 0.41% H: 0.0% C: 0.0%
biopharma sanofi

Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025Trial's lower-than-expected event rate suggests improved survival outcomes
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
PBLA | News | $0.4748 20K

| 11.9% | O: -4.76% H: 17.5% C: 17.5%
aspire for trial therapeutics

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
NRSN | News | $1.35 68K

| -4.93% | O: -1.41% H: 2.86% C: -3.57%
precision disease ongoing alzheimer's collaboration trial

Cidara Therapeutics Announces Reverse Stock Split
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
CDTX | News | $0.5021 -2.3% 1.2M

| -25.0% | O: -11.76% H: 8.33% C: -15.0%
therapeutics

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
RLYB | News | $1.83 3.39% 120K

| 0.57% | O: 1.14% H: 3.37% C: -0.56%
JNJ | News | $150.09 0.65% 3.9M

| 0.82% | O: 0.29% H: 0.0% C: 0.0%
VXRT | News | $0.7744 1.56% 350K

| 0.0% | O: 2.63% H: 2.56% C: -2.56%
TXMD | News | $1.88 8.6K

| 1.08% | O: 0.54% H: 3.21% C: 0.53%
SNY | News | $47.85 1.49% 920K

| 0.85% | O: 0.85% H: 0.0% C: 0.0%
PTCT | News S | $25.72 -0.96% 140K

| 2.57% | O: 0.08% H: 4.54% C: 2.49%
NKTR | News | $1.4 2.94% 600K

| 9.68% | O: 5.65% H: 7.63% C: 3.82%
MOR | News | $18.01 0.28% 130K

| -0.06% | O: -0.06% H: 0.0% C: 0.0%
GLPG | News | $29.695 2.15% 69K

| -0.03% | O: -0.41% H: 1.52% C: 0.38%
AMRN | News | $0.8888 2.67% 360K

| -1.17% | O: -2.31% H: 2.33% C: 1.16%
GOOGL | News S | $158.54 1.45% 11M

| 1.42% | O: 0.14% H: 2.16% C: 1.28%
GOOG | News S | $160.1 1.36% 7.6M

| 1.43% | O: 0.19% H: 2.04% C: 1.24%
OCX | News | $2.51 11K

| 0.4% | O: 0.8% H: 1.59% C: -0.4%
biopharma

Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff
Published: 2024-04-22 (Crawled : 16:00) - biospace.com/
RLYB | News | $1.83 3.39% 120K

| 0.57% | O: 1.14% H: 3.37% C: -0.56%
JNJ | News | $150.09 0.65% 3.9M

| 0.82% | O: 0.29% H: 0.0% C: 0.0%
VXRT | News | $0.7744 1.56% 350K

| 0.0% | O: 2.63% H: 2.56% C: -2.56%
TXMD | News | $1.88 8.6K

| 1.08% | O: 0.54% H: 3.21% C: 0.53%
SNY | News | $47.85 1.49% 920K

| 0.85% | O: 0.85% H: 0.0% C: 0.0%
PTCT | News S | $25.72 -0.96% 140K

| 2.57% | O: 0.08% H: 4.54% C: 2.49%
NKTR | News | $1.4 2.94% 600K

| 9.68% | O: 5.65% H: 7.63% C: 3.82%
MOR | News | $18.01 0.28% 130K

| -0.06% | O: -0.06% H: 0.0% C: 0.0%
GLPG | News | $29.695 2.15% 69K

| -0.03% | O: -0.41% H: 1.52% C: 0.38%
AMRN | News | $0.8888 2.67% 360K

| -1.17% | O: -2.31% H: 2.33% C: 1.16%
GOOGL | News S | $158.54 1.45% 11M

| 1.42% | O: 0.14% H: 2.16% C: 1.28%
GOOG | News S | $160.1 1.36% 7.6M

| 1.43% | O: 0.19% H: 2.04% C: 1.24%
OCX | News | $2.51 11K

| 0.4% | O: 0.8% H: 1.59% C: -0.4%
biopharma

Abeona Therapeutics Provides Regulatory Update on Pz-cel
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
ABEO | News | $3.555 -51.7% 3.2M

| Email alert Add to watchlist
update therapeutics

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
NBIX | News M | $139.71 4.53% 760K

| 0.0% | O: 5.43% H: 0.0% C: 0.0%
trials meeting set therapeutics therapy

← Previous
1
2
3
4
5
6
7
8
9
…
914
915
Next →

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.64 166.67% 18M

AGBA | $2.61 108.8% 41M

CZOO | $9.32 86.77% 18M

EDBL | News | $6.7 78.19% 1.7M

OPRT | News | $3.37 49.78% 8.9M

MTC | $2.14 37.18% 4.9M

VNRX | $0.8 33.33% 2.9M

MLEC | $1.79 27.86% 2.6M

n/a

PALI | $6.29 27.59% 22M

Manufacturing

MCRB | $0.7902 26.51% 6.9M